Subscribe to our Newsletters !!
Cell therapy is a medical breakthrough in addressi
Chromium, a transition metal with profound pharmac
Few names in the medical history have had a profou
We are pleased to announce that we have recently e
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and her
It is important to understand that natural remedie
Dear Readers, Welcome to the latest issue of Mi
Imagine a world where the battle against cancer no longer relies solely on the blunt instruments of chemotherapy and radiation therapy, which, while effective, often come at a high cost to the patient’s wellbeing. Immuno-oncology (IO) therapy has ushered in a new era by harnessing the body’s innate defenses to combat cancer cells and has already proven effective in treating bladder, breast, and colorectal cancers, among others.
As with any cutting-edge field, the landscape of IO therapy is vast and multifaceted. It stretches beyond a singular approach, encompassing a rich tapestry of methodologies and strategies aimed at augmenting our immune response. From immune-boosting drugs that galvanize our body’s defenses to monoclonal antibodies targeting specific cancer-related proteins, immunotherapy for cancer is a dynamic arena where innovation knows no bounds.
We mined the extensive CAS Content Collection™, the largest human-compiled multi-disciplinary database of documents and substances, to uncover the emerging trends and concepts in this broad and rapidly progressing field. There has been a steady increase in immunotherapy interest for cancer recently. (Figure 1).
Figure 1. Overall growth in publications (A) and increase in commercial interest (B) in immuno-oncology.
A thorough analysis of data sourced from the CAS Content Collection in cancer immunotherapy led us to a substantial dataset comprising over 350,000 publications, encompassing both journals and patents dedicated to this field. This analytical endeavor demanded a meticulous approach, beginning with subject matter experts (SMEs) crafting a highly specific search query. This was followed by Natural Language processing, allowing the identification of phrases and rigorous manual scrutiny by our SMEs to fine-tune those phrases. Ultimately, the carefully curated set of phrases was the foundation for deriving insights into the growth patterns of publications and citations from 2003 to 2022 — a CAS TrendScape®. (Figure 2).
Figure 2. CAS TrendScape® map of growth patterns in immunotherapy publications for cancer.
CLICK HERE TO DOWNLOAD THE CAS TRENDSCAPE
